Home>Topics>Stocks>Hologic

Hologic HOLX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Tracking Carl Icahn's Portfolio - Q2 2014 Update

      Headlines

      Tue, 19 Aug 2014

      By John Vincent : This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn's US stock portfolio on a quarterly basis. It is based on Icahn's regulatory 13F Form filed on 08/14/2014. Please visit our Tracking Carl Icahn's Portfolio series to get an idea of

    2. Markman hearing today regarding Enzo Biochem patents

      Headlines

      Mon, 18 Aug 2014

      important event in patent litigation. The company has outstanding patent disputes with Abbott Labs, Affymetrix, Agilent, Becton Dickinson, Gen-Probe, Hologic , Ilumina, Life Technologies, Luminex, Roche and Seimens. Post your comment!

    3. Hologic Remains Afloat as Key Franchises Offset Sluggish ThinPrep Volume

      Commentary

      Thu, 31 Jul 2014

      Hologic released strong third-quarter results ..... stable trend ratings also remain intact. Hologic ’s third-quarter revenue increased ..... continues to expand. On the cost side, Hologic ’s adjusted gross margin increased by

    4. Hologic's ( HOLX ) CEO Stephen MacMillan on Q3 2014 Results - Earnings Call Transcript

      Headlines

      Wed, 30 Jul 2014

      Hologic (NASDAQ: HOLX ) Q3 2014 Earnings Call July 30, 2014 4:30 pm ET Executives Deborah R. Gordon - Vice President of Investor Relations and Corporate

    5. Hologix ups revenue guidance after fiscal Q3 results

      Headlines

      Wed, 30 Jul 2014

      Hologix ( HOLX +1.7% ) fiscal Q3 results : Total Revenues: $632.6M (+1.0%); Gross Profit: $312.8M (+3.9%); Operating

    6. Notable earnings after Wednesday’s close

      Headlines

      Tue, 29 Jul 2014

      ELGX , ENTR , EQIX , EQY , ESRT , ESV , EXL , EXR , FBHS , FEIC , FISH , FMC , FNF , FOE , FORM , FORR , GLUU , HIG , HK , HOLX , HOS , HR , HTH , INT , IPI , ISIL , KBR , KEX , KGC , KRFT , KS , LGCY , LNC , LOCK , LPSN , LRCX , MAA , MANT , MDAS , MEOH

    7. New Morningstar Analyst Report for Abbott Laboratories

      Stock Reports

      Tue, 22 Jul 2014

      diagnostics arena where it must go head-to-head against market leader Roche, along with energetic upstarts like Qiagen and Hologic .Considering the heterogeneity involved in mitral valve disease, we are skeptical MitraClip will move beyond niche use for

    8. New Morningstar Analyst Report for Hologic Inc

      Stock Reports

      Fri, 27 Jun 2014

      market is in secular decline and could weigh on Hologic ’s results beyond 2014 should it take longer ..... for breast tomosynthesis will be lucrative for Hologic ’s customers.Despite Hologic ’s full pipeline and best efforts, a high degree

    9. New Study on 3D Mammography Reinforces Our Views on Hologic ’s Breast Health Franchise

      Commentary

      Thu, 26 Jun 2014

      Hologic made a number of headlines on June 25 with ..... narrow moat and stable trend ratings for Hologic remain intact, and we plan to maintain ..... falling within U.S. guidelines. However, Hologic ’s rollout of its recently approved C-view

    10. Hologic Garners Sales Momentum in Second Quarter

      Commentary

      Thu, 1 May 2014

      Hologic reported improved second-quarter earnings ..... to continued strength in the uptake of Hologic ’s 3D mammography equipment. While the ..... Panther systems remains encouraging, and Hologic appears capable of installing 1,000 units

    « Prev12345Next »
    Content Partners